BR0000707A - Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição - Google Patents

Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição

Info

Publication number
BR0000707A
BR0000707A BR0000707-2A BR0000707A BR0000707A BR 0000707 A BR0000707 A BR 0000707A BR 0000707 A BR0000707 A BR 0000707A BR 0000707 A BR0000707 A BR 0000707A
Authority
BR
Brazil
Prior art keywords
composition
oxothiazolidine
carboxylic acid
aqueous phase
neutralizer
Prior art date
Application number
BR0000707-2A
Other languages
English (en)
Inventor
Veronique Chevalier
Melanie Quest
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BR0000707A publication Critical patent/BR0000707A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

<B>"COMPOSIçãO DE FASE AQUOSA CONTìNUA, UTILIZAçãO DE PELO MENOS UM SEQUESTRANTE ASSOCIADO A PELO MENOS UM NEUTRALIZANTE, PROCESSO DE ESTABILIZAçãO DO áCIDO L-2-OXOTIAZOLIDINA 4-CARBOXìLICO E UTILIZAçãO DA COMPOSIçãO"<D> A presente invenção trata de uma composição de fase aquosa contúna que compreende ácido L-2-oxotiazolidina 4-carboxílico, pelo menos um seq³estrante e pelo menos um neutralizante, neutralizante esse que está presente em uma quantidade suficiente para ajustar o pH da fase aquosa da composição a um valor compreendido entre 5 e 8. A associação do seq³estrante e do neutralizante permite estabilizar o ácido L-2-oxotiazolidina 4-carboxílico diante, em particular, da degradação térmica e impedir assim um amarelecimento da composição bem como a formação de odores desagradáveis.
BR0000707-2A 1999-03-19 2000-03-13 Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição BR0000707A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903476A FR2790953B1 (fr) 1999-03-19 1999-03-19 Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique

Publications (1)

Publication Number Publication Date
BR0000707A true BR0000707A (pt) 2001-05-02

Family

ID=9543434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0000707-2A BR0000707A (pt) 1999-03-19 2000-03-13 Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição

Country Status (10)

Country Link
US (2) US6337077B1 (pt)
EP (1) EP1038515B1 (pt)
JP (1) JP4011820B2 (pt)
KR (1) KR100350914B1 (pt)
CN (1) CN1146387C (pt)
AT (1) ATE270869T1 (pt)
BR (1) BR0000707A (pt)
DE (1) DE60012068T2 (pt)
ES (1) ES2225037T3 (pt)
FR (1) FR2790953B1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790953B1 (fr) 1999-03-19 2002-08-09 Oreal Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique
FR2816838B1 (fr) * 2000-11-17 2004-12-03 Oreal Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
DE10155957A1 (de) * 2001-11-09 2003-05-22 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Hydroxybenzophenonen und Pentanatrium-Ethylendiamintetramethylenphosphonat
US7022317B2 (en) * 2003-04-25 2006-04-04 L'oreal Heterocyclic derivatives of 2-oxothiazolidine-4-carboxylic acid, and use as active photoprotective agents
US20070025947A1 (en) * 2005-07-29 2007-02-01 L'oreal Anti-acne method and kit
US20110104082A1 (en) * 2009-11-04 2011-05-05 Conopco, Inc., D/B/A Unilever Enhanced photo protection
US8173108B2 (en) * 2009-11-04 2012-05-08 Conopco, Inc. Sunscreen composition
US8206691B2 (en) * 2009-11-04 2012-06-26 Conopco, Inc. Sunscreen composition with fatty acid alkanolamides
US8883029B2 (en) * 2013-02-13 2014-11-11 Lam Research Corporation Method of making a gas distribution member for a plasma processing chamber

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665082A (en) 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
US5389657A (en) 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
US5840701A (en) * 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
AU7596994A (en) 1993-11-01 1995-05-18 Free Radical Sciences, Inc. Methods and compositions for retarding the aging process
EP0650725A1 (en) * 1993-11-03 1995-05-03 FREE RADICAL SCIENCES Inc Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione
EP0656201A1 (en) * 1993-11-09 1995-06-07 Transcend Therapeutics, Inc. Use of stimulators of glutathione synthesis as hait growth promotors
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
US6063389A (en) * 1995-12-22 2000-05-16 L'oreal Composition for depigmenting or bleaching mammalian skin containing L-2-oxothiazolidine-4-carboxylic acid and a polyol
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
FR2772613B1 (fr) * 1997-12-19 2003-05-09 Oreal Utilisation du phloroglucinol dans une composition cosmetique
FR2773323B1 (fr) * 1998-01-05 2000-02-11 Oreal Composition contenant une association de procysteine et de polyol
FR2778561B1 (fr) * 1998-05-14 2001-04-20 Oreal Azurants optiques comme agents blanchissants
FR2790953B1 (fr) 1999-03-19 2002-08-09 Oreal Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique

Also Published As

Publication number Publication date
CN1146387C (zh) 2004-04-21
ATE270869T1 (de) 2004-07-15
JP4011820B2 (ja) 2007-11-21
EP1038515A1 (fr) 2000-09-27
ES2225037T3 (es) 2005-03-16
KR100350914B1 (ko) 2002-08-28
CN1267507A (zh) 2000-09-27
KR20010006776A (ko) 2001-01-26
FR2790953A1 (fr) 2000-09-22
US6337077B1 (en) 2002-01-08
DE60012068T2 (de) 2005-09-01
DE60012068D1 (de) 2004-08-19
JP2000281521A (ja) 2000-10-10
FR2790953B1 (fr) 2002-08-09
US6872400B2 (en) 2005-03-29
US20030004197A1 (en) 2003-01-02
EP1038515B1 (fr) 2004-07-14

Similar Documents

Publication Publication Date Title
EP0832643A3 (en) Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
IL114212A (en) Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
BR0006005A (pt) Composição estável de óleo em glicerinatopicamente aplicável
DE69427498D1 (de) Verfahren zur Stabilisierung von Vesikeln aus amphiphilen Lipiden und diese stabilisierte Vesikeln enthaltende Zusammensetzung für die topische Anwendung
SE9401108D0 (sv) Ophthalmic composition I
DE69333605D1 (de) Stabile injizierbare Paclitaxel Lösung
DE69519667D1 (de) Verfahren zur stabilisierung von duocarmycinderivaten
KR950007858A (ko) 정맥내 주사용 라파마이신 제형
DE708649T1 (de) Präparation und stabilisation von zellen
BR0000707A (pt) Composição de fase aquosa contìnua, utilização de pelo menos um sequestrante associado a pelo menos um neutralizante, processo de estabilização do ácido l-2- oxotiazolidina 4-carboxìlico e utilização da composição
WO2002026277A3 (en) Stabilized hydrogen peroxide solutions
DE69614110T2 (de) Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d&#39;une émulsion huile-dans-l&#39;eau stable contenant au moins une huile végétale constituée d&#39;au moins 40% de triglycérides d&#39;acide linoléique.
FR2818903B1 (fr) Composition transparente de traitement cosmetique, de type emulsion eau-dans-huile, et procede de traitement cosmetique des matieres keratiniques
AU2668800A (en) Mixture of plant-treatment agents and waxes, method for producing same and the use thereof
TW256831B (pt)
ATE132861T1 (de) Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FR2742048B1 (fr) Utilisation de l&#39;alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
DE69940051D1 (de) Wasserlösliche trockene zusammensetzungen
IE870410L (en) Amphoteric surfactant for contact lenses
ES2196425T3 (es) Emulsiones cosmeticas y dermatologicas que contienen glucosidos alquilicos y elevadas concentraciones de electrolitos.
BR9910549A (pt) Composições estabilizadas, processo para estabilização de material de amÈnio quaternário, condicionadores de rinsagem sólido e lìquido, e, processo para reduzir o nìvel de descoloração do material de amÈnio quaternário.
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
DE69705047D1 (de) Stabilisierte und gepufferte wasserstoffperoxidlösung, verfahren zur deren herstellung und verwendung zur dekontamination von kontaktlinsen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A E 11A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/49 (2006.01), A61Q 7/00 (2006.01), A61Q 17/